Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644767
What this trial is testing
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression
Who this might be right for
Treatment Resistant Bipolar Depression
Neurocentrx Pharma Pty Ltd 160